Y-mAbs Therapeutics (YMAB) Insider Trading & Ownership $4.49 -0.17 (-3.58%) As of 10:03 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Y-mAbs Therapeutics (NASDAQ:YMAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$2.62 M Get YMAB Insider Trade Alerts Want to know when executives and insiders are buying or selling Y-mAbs Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address YMAB Insider Buying and Selling by Quarter Remove Ads Y-mAbs Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2025Michael J RossiCEOSell3,917$5.20$20,368.40 3/7/2025Thomas GadInsiderSell10,810$5.23$56,536.30 9/16/2024Thomas GadInsiderSell30,000$12.97$389,100.00 9/13/2024Thomas GadInsiderSell65,000$13.47$875,550.00 8/26/2024Joris WilmsCOOSell5,000$14.69$73,450.00 6/10/2024Gerard BerDirectorSell722$12.00$8,664.00 6/10/2024Thomas GadInsiderSell35,000$12.03$421,050.00 5/31/2024Bo KruseCFOSell31,371$12.07$378,647.97 5/23/2024Thomas GadInsiderSell7,351$13.00$95,563.00 5/21/2024Thomas GadInsiderSell25,000$12.00$300,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) YMAB Insider Trading Activity - Frequently Asked Questions Who is on Y-mAbs Therapeutics's Insider Roster? The list of insiders at Y-mAbs Therapeutics includes Biotech Aps Wg, Bo Kruse, Gerard Ber, Johan Wedell-Wedellsborg, Joris Wilms, Michael J Rossi, Thomas Gad, and Vignesh Rajah. Learn more on insiders at YMAB. What percentage of Y-mAbs Therapeutics stock is owned by insiders? 22.50% of Y-mAbs Therapeutics stock is owned by insiders. Learn more on YMAB's insider holdings. Which Y-mAbs Therapeutics insiders have been buying company stock? The following insiders have purchased YMAB shares in the last 24 months: Biotech Aps Wg ($1,070,726.02), and Johan Wedell-Wedellsborg ($1,325,003.84). How much insider buying is happening at Y-mAbs Therapeutics? Insiders have purchased a total of 325,139 YMAB shares in the last 24 months for a total of $2,395,729.86 bought. Which Y-mAbs Therapeutics insiders have been selling company stock? The following insiders have sold YMAB shares in the last 24 months: Bo Kruse ($378,647.97), Gerard Ber ($8,664.00), Joris Wilms ($73,450.00), Michael J Rossi ($20,368.40), Thomas Gad ($3,194,799.30), and Vignesh Rajah ($28,282.83). How much insider selling is happening at Y-mAbs Therapeutics? Insiders have sold a total of 390,882 Y-mAbs Therapeutics shares in the last 24 months for a total of $3,704,212.50 sold. Y-mAbs Therapeutics Key ExecutivesMr. Thomas Gad (Age 53)Founder, Chief Business Officer & Vice Chairman Compensation: $1.05M1 recent tradesMr. Bo Kruse (Age 51)Executive VP, Secretary, Treasurer & CFO Compensation: $685.02kMs. Susan Smith (Age 53)Senior VP & Chief Commercial Officer Compensation: $710kMr. Michael Rossi (Age 53)CEO, President & Director 1 recent tradesMr. Joris Wiel Jan Wilms (Age 50)Senior VP & COO Dr. Torben Lund-Hansen M.Sc. (Age 73)Ph.D., Senior VP & CTO Dr. Steen Lisby M.D. (Age 60)M.Sc., Senior VP & Chief Scientific Officer Compensation: $393.99kMs. Courtney DuganVice President of Investor RelationsDr. Vignesh Rajah M.B.A. (Age 59)MBBS, Senior VP & Chief Medical Officer Compensation: $406.27k More Insider Trading Tools from MarketBeat Related Companies CDMO Insider Trading CMRX Insider Trading EOLS Insider Trading PRAX Insider Trading AVDL Insider Trading REPL Insider Trading XNCR Insider Trading NTLA Insider Trading AVXL Insider Trading GYRE Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:YMAB) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Y-mAbs Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy YMAB Stock Free YMAB Stock Alerts